Low baseline salivary alpha-amylase in drug-naïve patients with short-illness-duration first episode major depressive disorder

Journal of Affective Disorders

Volumn 157, Issue , 2014, Pages 14-17

  Cubała, Wiesław Jerzy ^a   Landowski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Autonomic nervous system; Drug na ve individuals; Major depressive disorder; Noradrenaline; Salivary alpha amylase

Indexed keywords

ALPHA AMYLASE SALIVA ISOENZYME;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; HYPERACTIVITY; HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MALE; MELANCHOLIA; MIDDLE AGED; NEUROTRANSMISSION; PRIORITY JOURNAL; SALIVA ANALYSIS; SAMPLE SIZE;

AUTONOMIC NERVOUS SYSTEM; DRUG-NAÏVE INDIVIDUALS; MAJOR DEPRESSIVE DISORDER; NORADRENALINE; SALIVARY ALPHA-AMYLASE;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SALIVARY ALPHA-AMYLASES;

EID: 84893283977     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.12.043     Document Type: Article

References (20)

1. S.L. Bagley, T.L. Weaver, and T.W. Buchanan Sex differences in physiological and affective responses to stress in remitted depression Physiol. Behav. 104 2011 180 186
2. J.A. Bosch, E.C. Veerman, E.J. de Geus, and G.B. Proctor α-Amylase as a reliable and convenient measure of sympathetic activity: don't start salivating just yet! Psychoneuroendocrinology 36 2011 449 453
3. R.M. Carney, K.E. Freedland, and R.C. Veith Depression, the autonomic nervous system, and coronary heart disease Psychosom. Med. 67 Suppl. 1 2005 S29 S33
4. K. Chopra, B. Kumar, and A. Kuhad Pathobiological targets of depression Expert Opin. Ther. Targets 15 2011 379 400
5. U. Ehlert, K. Erni, G. Hebisch, and U. Nater Salivary alpha-amylase levels after yohimbine challenge in healthy men J. Clin. Endocrinol. Metabol. 91 2006 5130 5133 (Pubitemid 44917363)
6. A.S. Elhwuegi Central monoamines and their role in major depression Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 2004 435 451 (Pubitemid 38490755)
7. M.B. First, R.L. Spitzer, M. Gibbon, and J.B.W. Williams Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) 1997 American Psychiatric Press Washington, DC
8. S.M. Guinjoan, J.L. Bernabó, and D.P. Cardinali Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression J. Neurol. Neurosurg. Psychiatry 59 1995 299 302
9. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
10. M. Hamon, and P. Blier Monoamine neurocircuitry in depression and strategies for new treatments Prog. Neuro-Psychopharmacol. Biol. Psychiatry 45 2013 54 63
11. Y. Ishitobi, J. Akiyoshi, Y. Tanaka, T. Ando, S. Okamoto, M. Kanehisa, K. Kohno, T. Ninomiya, Y. Maruyama, J. Tsuru, A. Kawano, H. Hanada, K. Isogawa, and K. Kodama Elevated salivary α-amylase and cortisol levels in unremitted and remitted depressed patients Int. J. Psychiatry Clin. Pract. 14 2010 268 273
12. F. Lamers, N. Vogelzangs, K.R. Merikangas, P. de Jonge, A.T. Beekman, and B.W. Penninx Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression Mol. Psychiatry 18 2013 692 699
13. M. Lehofer, M. Moser, R. Hoehn-Saric, D. McLeod, P. Liebmann, B. Drnovsek, S. Egner, G. Hildebrandt, and H.G. Zapotoczky Major depression and cardiac autonomic control Biol. Psychiatry 42 1997 914 919 (Pubitemid 27486445)
14. A. McGirr, G. Diaconu, M.T. Berlim, J.C. Pruessner, R. Sablé, S. Cabot, and G. Turecki Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicide J. Psychiatry Neurosci. 35 2010 399 408
15. U.M. Nater, and N. Rohleder Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research Psychoneuroendocrinology 34 2009 486 496
16. S. Schumacher, C. Kirschbaum, T. Fydrich, and A. Ströhle Is salivary alpha-amylase an indicator of autonomic nervous system dysregulations in mental disorders? A review of preliminary findings and the interactions with cortisol Psychoneuroendocrinology 38 2013 729 743
17. Y. Tanaka, Y. Ishitobi, Y. Maruyama, A. Kawano, T. Ando, S. Okamoto, M. Kanehisa, H. Higuma, T. Ninomiya, J. Tsuru, H. Hanada, K. Kodama, K. Isogawa, and J. Akiyoshi Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients Prog. Neuro-Psychopharmacol. Biol. Psychiatry 36 2012 220 224
18. G. Veen, E.J. Giltay, C.M. Licht, S.A. Vreeburg, C.M. Cobbaert, B.W. Penninx, and F.G. Zitman Evening salivary alpha-amylase, major depressive disorder, and antidepressant use in the Netherlands Study of Depression and Anxiety (NESDA) Psychiatry Res. 208 2013 41 46
19. G. Veen, E.J. Giltay, S.A. Vreeburg, C.M. Licht, C.M. Cobbaert, F.G. Zitman, and B.W. Penninx Determinants of salivary evening α-amylase in a large sample free of psychopathology Int. J. Psychophysiol. 84 2012 33 38
20. R.C. Veith, N. Lewis, O.A. Linares, R.F. Barnes, M.A. Raskind, E.C. Villacres, M.M. Murburg, E.A. Ashleigh, S. Castillo, E.R. Peskind, M. Pascualy, and J.B. Halter Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics Arch. Gen. Psychiatry 51 1994 411 422 (Pubitemid 24176819)